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Mammalianprimordial germ cells (PGCs) are unipotent progenitors of the gametes. Nonetheless, they can give rise directly to pluripotent
stem cells in vitro or during teratocarcinogenesis. This conversion is inconsistent, however, and has been difficult to study. Here, we
delineate requirements for efficient resetting of pluripotency in culture. We demonstrate that in defined conditions, routinely 20% of
PGCs become EG cells. Conversion can occur from the earliest specified PGCs. The entire process can be tracked from single cells.
It is driven by leukemia inhibitory factor (LIF) and the downstream transcription factor STAT3. In contrast, LIF signaling is not required
during germ cell ontogeny. We surmise that ectopic LIF/STAT3 stimulation reconstructs latent pluripotency and self-renewal. Notably,
STAT3 targets are significantly upregulated in germ cell tumors, suggesting that dysregulation of this pathwaymayunderlie teratocarcino-
genesis. These findings demonstrate that EG cell formation is a robust experimental system for exploring mechanisms involved in
reprogramming and cancer.INTRODUCTION
In sexually reproducing organisms germ cells provide the
continuous link between the generations, delivering the ge-
netic andepigenetic informationrequired toconstruct anew
organism (Surani, 2007). Primordial germ cells (PGCs) repre-
sent the founder cells of the germline lineage. In mice, they
are induced from Oct4- (also known as Pou5f1) positive
pluripotent epiblast cells at the onset of gastrulation. By
E7.5, PGCs are said to be specified, coincident with the
expression of Stella (also known as Dppa3, Pgc7) (McLaren
and Lawson, 2005; Saitou et al., 2002).Duringnormal devel-
opment, PGCsbehaveasunipotentprogenitors andproduce
onlygermcells.Yet, theyexpress pluripotencygenesuntil af-
ter colonization of the genital ridges (Surani et al., 2007).
Significantly, PGCs can give rise to pluripotent tumors in
ectopic sites and they can serve as the cell of origin of testic-
ular teratocarcinomas (Stevens, 1967). Ex vivo PGCs can
directly give rise to pluripotent stem cell lines known as em-
bryonic germ (EG) cells (Matsui et al., 1992; Resnick et al.,
1992). Like embryonic stem(ES) cells, EGcells are genetically
normal andarecapableof contributing tochimeras (Labosky
et al., 1994; Stewart et al., 1994).
The process by which PGCs convert to pluripotency is
erratic and poorly characterized. Three growth factors are
reported to play key roles; stem cell factor (SCF), leukemia
inhibitory factor (LIF), and basic fibroblast growth factor
(bFGF). Individually, each factor positively influences PGC
proliferation and/or survival (Dolci et al., 1991; Godin
et al., 1991; Matsui et al., 1991), but in combination they
facilitate conversion to EG cells. Only LIF plays a role in sub-66 Stem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The Authorssequent self-renewal of EG cells. bFGF is important during
the first day of culture but not thereafter, suggesting it may
trigger the conversion process (Durcova-Hills et al., 2006).
bFGF appears to act though the PI3K/AKT pathway because
it is not required for EG cell formation from Pten deletion
mutants (Kimura et al., 2003) or if AKT is hyperactivated (Ki-
mura et al., 2008). Retinoic acid (RA) and forskolin (FK), two
potent PGC mitogens, can substitute for bFGF in EG cell
derivation (Koshimizu et al., 1996), as can thehistone deace-
tylase inhibitor trichostatin A (Durcova-Hills et al., 2008).
However, whether the activity of these factors is direct or
mediated through inductionof FGFsor other factors remains
unclear due to the complex culture conditions, which in-
clude serum, feeders, andheterogeneous somatic cells. Previ-
ously, we showed that addition of two smallmolecule inhib-
itors of mitogen-activated protein kinase (MAPK) signaling
and glycogen synthase kinase 3 (GSK3) (2i) (Ying et al.,
2008) enables reliable generation of EG cells from mouse
and rat PGCs (Leitch et al., 2010; Blair et al., 2012).However,
undefined components should be eliminated to delineate
the individual contributions of signaling molecules and
pathways that mediate the derestriction of PGCs to pluri-
potency. Here, we develop a defined culture system and ex-
ploit this to clarify pathway requirements and in addition
to track the PGC to EGcell conversion at the single cell level.
RESULTS
EG Cell Derivation Does Not Require Serum or Feeders
EG cells can be obtained after plating PGCs directly in
2i/LIF on feeders (Leitch et al., 2010). Past attempts to
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death within 24 hr (De Felici et al., 1998). We therefore
investigated whether addition of known PGC-supportive
factors might increase proliferation and viability. Posterior
regions ofmouse E8.5 embryos were trypsinized and plated
in 2i/LIF, with the addition of bFGF, SCF, RA, and FK
(henceforth referred to collectively as four factors—4Fs)
for the first 2 days only. In these feeder-free conditions,
EG cell lines were readily obtained. However the addition
of the 4Fs resulted in substantial growth of somatic cells
(data not shown) calling into the question the cell-autono-
mous ability of PGCs to produce EG cells. Therefore, we
used flow cytometry to obtain a pure population of PGCs
(Figures S1A and S1B available online). This approach
enabled accurate calculation of derivation efficiency (per-
centage of PGCs forming colonies), which on fibronectin
approached 4% (Figure S1C.) Previously, it has been sug-
gested that inhibition of MAPK has a negative effect on
PGC proliferation (De Miguel et al., 2002). Therefore, we
plated equal numbers of flow-sorted PGCs on fibronectin
in either 2i/LIF or GSK3 inhibitor plus LIF (CH/LIF). Over
the first 72 hr, many more PGCs were evident per cluster
in the CH/LIF cultures; however, many, although not all,
of the cells downregulated the Oct4-DPE-GFP reporter
that is active in both PGCs and EG cells. By 7 days, only
a small number of EG cell colonies were present in CH/
LIF compared with 2i/LIF (Figure 1A). These colonies
in CH/LIF were partially differentiated, but they had a
tightly packed core with EG cell morphology and after
picking cells could be expanded in 2i/LIF indistinguish-
ably from other EG cells.
These results indicate that while MAPK inhibition con-
tributes substantially to the production of EG cells, it may
impair the initial viability of PGCs. We therefore investi-
gated whether delayed inhibition of MAPK may reduce
early cell death and improve overall conversion efficiency.
We plated 250 flow-sorted PGCs on fibronectin in CH/LIF
plus 4Fs, with or without PD, for the first 48 hr and there-
after transitioned to 2i/LIF by half-medium changes (Fig-
ure 1B). After 12 days, 72 Oct4-DPE-GFP colonies were
obtained in cultures initiated in CH, compared with only
six from2i (Figure 1C). In the course of scoring these plates,
we also noted that some EG cell colonies were clustered
together, raising the possibility that single PGCs may pro-
duce more than one colony (see later). However, even
when colony clusters are scored as single conversion
events, deferring addition of PD for 48 hr leads to a 10-
fold increase in yield (Figure 1C). All subsequent experi-
ments were thus performed using these conditions unless
otherwise stated.
We investigated formation of EG cells from gonadal
PGCs at E11.5. From 2,000 PGCs per well, we recovered a
maximum of seven EG cells colonies per well (Figure 1D).The conversion frequency of 1/286 is some 50-fold lower
than for E8.5 PGCs. This is consistent with previous reports
of increasing refractoriness as development progresses
(Durcova-Hills and Capel, 2008; Labosky et al., 1994). EG
cells have never been derived frombefore E8.0 even though
PGCs are specified at E7.5 (Labosky et al., 1994; McLaren
and Lawson, 2005). To test whether early PGCs are compe-
tent to produce EG cells, we collected embryos at the early/
midallantoic bud stage, excluding late head-fold stage
embryos. We dissected the posterior section of 23 embryos
carrying the Oct4-DPE-GFP transgene and were able to
recover 98GFP-positive cells by flowcytometry (Figure 1H).
After 10 days of culture, we obtained a total of 13 EG cell
colonies. Three colonies appeared close together and
another two were doublets (Figures 1E and 1H). Assuming
clustered colonies derive from one starting cell gives a
corrected conversion frequency of 10/98. Importantly,
GFP-negative cells did not yield any colonies. However,
the expression of the Oct4-DPE-GFP transgene is not
completely restricted to PGCs at this time point (Yoshimizu
et al., 1999). To confirm that the colonies obtained were
derived from PGCs rather than late epiblast or other cells,
we repeated the experiment using Blimp1-GFP or Stella-
GFP reporters. From five E7.5 Blimp1-GFP embryos, we
obtained 2,000 GFP-positive cells. As only 20–40 PGCs
are present at this stage, the majority of these cells were
presumably visceral endodermal where Blimp1 is also ex-
pressed (Ohinata et al., 2005). Indeed, we observed many
patches of endodermal-like cells growing in the cultures
(Figure 1F). However, we also obtained 15 EG cell colonies
in eight distinct clusters (Figures 1F and 1H). These colonies
were Blimp1-GFP negative at the end of the experiment,
which is expected because BLIMP1 is rapidly downregu-
lated during EG derivation (Durcova-Hills, et al., 2008),
and the expression of Blimp1 in ES cells in 2i/LIF is negli-
gible (Figure 1F; Marks et al., 2012). Stella-GFP is upregu-
lated around E7.5 specifically in PGCs (Payer et al., 2006).
In two separate experiments, we were able to isolate 45
and 47 Stella-GFP-positive PGCs that produced eight and
ten colony clusters, respectively, representing an EG-cell-
derivation efficiency of approximately 20% (Figures 1G
and 1H). Overall, these findings are comparable to EG cell
generation from purified E8.5 PGCs. To confirm the iden-
tity and potency of E7.5 EG cells, we produced chimeras.
We first introduced a DsRed reporter transgene to Stella-
GFP-derived EG cells using the PiggyBac system. EG cells
stably transfected with a DsRed expression construct (Guo
et al., 2009) were injected into blastocysts and transferred
to recipient pseudopregnant hosts. Pregnant females were
sacrificed at midgestation, and four out of nine embryos
exhibited widespread chimerism (Figure 1I). Unlabeled
EG cells were also injected into blastocysts, transferred
to pseudopregnant hosts, and left to term. Coat colorStem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The Authors 67
Figure 1. Efficient EG Cell Derivation in
Defined Conditions without Serum or
Feeders
(A) Histogram showing EG-cell-colony fre-
quency in 2i/LIF versus CH/LIF. The four
factors (4Fs), bFGF, SCF, FK, and RA, were
added for the first 48 hr of culture. Error
bars denote SE of two biological replicates.
**p < 0.01, Student’s t test.
(B) Schematic of derivation protocol. PGCs
were plated in CH/LIF plus 4Fs, with or
without PD for the first 48 hr. All cultures
were subsequently fed with 2i/LIF.
(C) Quantitation of EG-cell-colony fre-
quency in each condition.
(D) Histogram showing EG-cell-colony
formation from E11.5 PGCs in 2i/LIF and
CH/LIF. The four factors (4Fs), bFGF, SCF,
FK, and RA, were added for the first 48 hr of
culture. All cultures were subsequently fed
with 2i/LIF. Error bars denote SE of three
biological replicates. Phase and fluores-
cence images show a primary E11.5 EG cell
colony.
(E–G) FACS plot showing gated GFP-positive
E8.5 PGCs and phase-contrast and fluores-
cence images of primary EG cell colonies
derived from (E) Oct4-DPE-GFP embryos, (F)
Blimp1-GFP embryos, and (G) Stella-GFP
embryos.
(H) Summary of E7.5 EG-cell-derivation ex-
periments.
(I) Bright-field and fluorescence images of
E11.5 chimeric embryos made from aggre-
gations of E7.5 EG cells carrying a consti-
tutively active DsRed reporter transgene.
(J) Coat color chimeras generated with
agouti E7.5 EG cells injected into C57BL/6
blastocysts (upper panel) and an adult
chimera with C57BL/6 mate and brown pup,
indicating transmission of the EG cell
genome (lower panel).
Scale bars, 100 mm. See also Figure S1 and
Table S1.
Stem Cell Reports
Rebuilding Pluripotency from Primordial Germ Cellschimerism was evident in 5/15 pups (Figure 1J; Table S1).
One of these chimeras was test mated and gave germline
transmission (Figure 1J). We conclude that from specifica-
tion PGCs have the capacity to form pluripotent EG cell
lines.
Single PGCs Efficiently Give Rise to EG Cells
To establish if isolated PGCs are capable of forming EG
cells, individual Oct4-DPE-GFP-positive PGCs from E8.5
embryos were flow-sorted into 96-well plates containing
CH/LIF plus 4Fs with or without PD (Figure 2A). Each68 Stem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The Authorswell was examined by microscopy 4 hr after deposition,
and none was found to contain more than one cell,
although some mitotic figures were observed. Twenty-
four hours after deposition, each well was again examined,
and cells were present in 56/96 and 61/96 wells with or
without PD, respectively (Figure 2B). As above, cultures
were transitioned to 2i/LIF by daily half-medium changes
from 48 hr. After 12 days, each well was assessed for the
presence of EG cells (Figure 2B). In the plate initiated
in 2i, there were three positive wells, one containing two
colonies. In the CH/LIF plate, 12 cells (18%) yielded EG
Figure 2. EG Cell Derivation from Single PGCs
(A) Schematic of derivation protocol. Oct4-DPE-GFP-positive PGCs were deposited singly into each well of a 96-well plate, in medium
containing CH/LIF+4Fs with or without PD. After 48 hr, cultures were transitioned to 2i/LIF by daily half-medium changes.
(B) Summary of results obtained from each 96-well plate.
(C) Single frames from time-lapse movie of EG cell derivation. Arrow denotes PGC that produces all nine EG cells colonies. Cells with PGC-
like morphology proliferate up until approximately 85 hr. By 112.5 hr, extensive cell death is evident. At 154.5 hr, small colonies are
evident and have expanded by 179 hr. The final image shows Oct4-DPE-GFP expression in EG cell colonies at 179 hr. See also Movie S1.
(D) Coat color chimera (generated with agouti EG cells derived from a colony in C) with C57BL/6 mate and all brown litter, indicating
successful germline transmission.
See also Figure S2 and Table S1.
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note that if total colonies are divided by the number of
PGCs plated, then the calculated derivation efficiency
would be 31.1%. Thus, the enumeration method routinely
used for bulk culture experiments overestimates the actual
number of starting PGCs that convert.We carried out time-lapse analyses to visualize the
process of EG cell generation and observe how multiple
colonies may be produced. Ten PGCs were plated in each
well of a 96-well plate and the progeny of single PGCs
tracked over 179 hr. We observed that in clones that gener-
ated EG cells many sister cells died. We also found severalStem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The Authors 69
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onies. These generally arose independently from separate
daughter cells rather than by colony splitting (Figure 2C;
Movie S1). We picked ten colonies originating from
different PGCs, and five derived from the same PGC. All
could readily be expanded as EG cell lines. One was in-
jected into blastocysts and gave rise to coat color chimeras
(Figure 2D; Table S1). A chimera was test mated and ex-
hibited germline transmission (Figure 2E), confirming
naive pluripotent identity and functionality.
Signaling Requirements for EG Cell Formation
Next, we investigated the stimuli required to enable con-
version of PGCs to EG cells. Sorted PGCs were cultured as
above but with individual factors removed. Withdrawal
of forskolin had no effect, but without initial exposure
to SCF or RA there was a significant reduction in colony
numbers (Figure 3A). Fewer colonies were also obtained
without bFGF. Thus, all three of these factors contribute
to the starting period of EG cell derivation though none
is essential. Interestingly, although LIF has been reported
to increase the survival and proliferation of PGCs (Matsui
et al., 1991), we did not observe an overt effect on PGC
survival or proliferation during the early stages of culture
(Figure 3B), and EG-cell-colony formation is not signifi-
cantly affected by the absence of LIF during the first 48 hr
of culture (Figure 3C). However, colony number is reduced
if LIF is withheld for a further 24 hr, andmost significantly,
in the continuous absence of LIF no colonies are obtained
(Figure 3A).
We assessed the duration of LIF stimulation required to
enable conversion. When LIF is present from the start and
removed by medium washout after 72 hr, a small number
of colonies are obtained. The yield increases after 96 hr in
LIF and further after 120 hr (Figure 3D). However, medium
change may not be sufficient to completely eliminate the
LIF signal. Therefore, we combined LIF removal with addi-
tion of an inhibitor of Janus-associated kinases (JAK) to
block ongoing signaling (Figure 3D). Under these condi-
tions, no colonies are recovered unless prior LIF stimula-
tion has been maintained for 144 and 192 hr exposure is
needed to reach control efficiency (Figure 3D). These find-
ings indicate that prolonged LIF stimulation between 48
and 192 hr is required to maximize EG cell formation.
STAT3 is the key mediator of LIF effects both on ES cell
self-renewal (Matsuda et al., 1999; Niwa et al., 1998) and
in EpiSC and somatic cell reprogramming (Bao et al.,
2009; van Oosten et al., 2012; Yang et al., 2010). We com-
pared the expression pattern of LIF/STAT3 targets (Bourillot
et al., 2009) in single-cell RNA-seq data sets from E8.5
PGCs and ES cells (Hackett et al., 2012; Tang et al., 2010).
The expression of 37 annotated STAT3 target genes was
significantly enriched in ES cells (Welch’s t test, p < 0.01)70 Stem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The Authors(Figure 3E). This is consistent with a requirement to
activate LIF signaling and targets for PGC conversion. We
used immunostaining to detect the emergence of KLF4, a
validated LIF/STAT3 target and pluripotency factor (Hall
et al., 2009; Li et al., 2005; Niwa et al., 2009), which has
previously been shown to be upregulated during EG cell
derivation (Durcova-Hills et al., 2008; Nagamatsu et al.,
2012) (Figure 3F). Positive cells were first detected at
96 hr, but, in contrast to established EG cell cultures in
2i/LIF, KLF4 expression is mosaic within colonies (Fig-
ure 3F). This heterogeneity is manifest even after 120 hr,
although colonies with a more homogenous KLF4 staining
pattern can also be observed by this stage (Figure 3F). These
observations indicate that KLF4 expression develops asyn-
chronously and is progressively consolidated during EG
cell formation.
To establish whether STAT3 function is in fact required
for EG cell derivation, we performed knockdown experi-
ments during the conversion process using small inter-
fering RNA (siRNA). The efficiency and specificity of
siRNAs was confirmed in ES cells (Figure S2). PGCs were
plated in CH plus 4Fs in the absence of LIF for 30 hr prior
to siRNA transfection. Following transfection, culture
medium was changed to 2i/LIF and colonies were counted
after 12 days. Transfection was associated with some
cellular toxicity, reducing the colony yield from control
siGFP-transfected cells by approximately 50% (Figure 3G).
However, over and above this effect, STAT3 knockdown
abolished EG-cell-colony formation completely in each
of several independent experiments (Figure 3G). We
conclude that STAT3 is required to mediate conversion
of PGCs to EG cells.
STAT3 Targets Are Upregulated in Germ Cell Tumors
The preceding results suggest that signaling through the
LIF/STAT3 pathway is low or absent in PGCs and that
activation of STAT3 targets drives regeneration of pluripo-
tency during EG cell derivation. PGCs can be the cells of
origin during teratocarcinogenesis, andmany pluripotency
genes are found to be upregulated in human germ cell
tumors (Oosterhuis and Looijenga, 2005). We therefore
investigated the expression of the STAT3 targets in a hu-
man germ cell tumor (GCT) microarray data set (Korkola
et al., 2006; West et al., 2009). We found widespread upre-
gulation of these target genes in GCTs compared with low
expression in normal testes (Figure 4A). We used these
STAT3 target genes to construct a KEGG pathway (‘‘Savatier
STAT3 targets’’) and found this to be the fifth most upregu-
lated pathway when comparing all GCTs with normal
testes (Figure 4B). However, only a subset of human GCTs
is thought to undergo teratocarcinogenesis (Oosterhuis
and Looijenga, 2005). Of these, embryonal carcinomas
contain a pluripotent cell compartment and exhibit a
Figure 3. LIF/STAT3 Drives Acquisition of Pluripotency
(A) Histogram showing EG-cell-colony numbers obtained from flow-sorted PGCs plated either in CH/LIF+4Fs (control) or with the indicated
factor removed. After 48 hr, cultures were transitioned to 2i/LIF (or 2i only in the –LIF condition) by daily half-medium changes (mean ±
SEM, *p < 0.05, **p < 0.01, and***p < 0.001, ANOVAwithDunnett’s post hoc, here and for all other figures, unless otherwise stated) (n = 12).
(B) Phase-contrast image after 65.2 hr in minus LIF and plus LIF conditions, showing the daughter cells derived from single PGCs.
(C) Histogram showing EG-cell-colony numbers obtained from flow-sorted PGCs plated in CH+4Fs. After 48 hr, cultures were transitioned to
2i by daily half-medium changes. LIF was added either from the start of the experiment (0 hr) or at the time indicated, and maintained
thereafter (n = 12).
(D) Histogram showing EG-cell-colony numbers obtained from flow-sorted PGCs. At the times indicated, either LIF was removed
by changing the medium (gray bars) or LIF was removed and a JAK inhibitor added (blue bars). In the control, LIF was present throughout
(n = 8).
(legend continued on next page)
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et al., 2003). Notably, STAT3 target genes are the second
most upregulated KEGG pathway in embryonal carcinoma
(EC) samples, second only to ‘‘ribosome’’ (Figure S3A).
Mixed GCTs often contain an EC component and STAT3
targets are ranked fourth of the upregulated pathways
in this group (Figure S3B). Teratomas consist only of differ-
entiated cell types and have low expression of pluripo-
tency-associated genes (Figure 4A) but are believed to pass
through a pluripotent cell intermediate. Intriguingly,
they still exhibit a strong enrichment for STAT3 target
genes (Figure S3C). Reactivation of pluripotency does not
occur in seminomas (Oosterhuis and Looijenga, 2005),
which retain expression of germline genes (Figure 4A).
Consistently, STAT3 targets are less enriched in the semi-
noma samples, and also in yolk sac tumors, the etiology
of which remains unclear (Figures S3D and S3E). These
data suggest that STAT3 activation may be a primary lesion
in germ cell tumors that transit through pluripotency.DISCUSSION
Mammalian primordial germ cells are considered unipo-
tent, giving rise only to the gametes. Indeed, the sperm
and egg represent two of the most overtly differentiated
cell phenotypes. Yet, these two specialized cells regain
access to the entire embryonic and extraembryonic
differentiation programs following fertilization and zygotic
reprogramming. Immature cells of the germline can also
acquire pluripotency through nonphysiological routes,
ex vivo formation of EG cells and multipotent germline
stem cells (Kanatsu-Shinohara et al., 2004), or in vivo tera-
tocarcinogenesis. However, those events have previously
been obtained at low frequency in complex environments.
Here, we demonstrate that 10%–30% of single mouse
PGCs can convert to pluripotent EG cells in well-defined
conditions. This is comparable to the efficiency of ES cell
derivations reported from single epiblast cells (Brook and
Gardner, 1997; Rugg-Gunn et al., 2012) and challenges
the notion that PGCs are an intrinsically committed unipo-
tent lineage.
PGC identity depends on the activity of determinants
such as Blimp1 (Ohinata et al., 2005), Prdm14 (Yamaji(E) Mean reads per million (RPM) of STAT3 target genes in Oct4-positi
reveals a higher expression in ES cells than PGCs.
(F) OCT4 and KLF4 immunostaining of an established EG cell line and n
staining exhibits either heterogenous (i) or homogenous (ii) stainin
clarity. Scale bar 100 mm.
(G) Histogram indicating EG-cell-derivation efficiency, relative to an u
siRNAs targeting STAT3 and a negative control siRNA (siGFP) (error ba
n = 2).
72 Stem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The Authorset al., 2008), and Tcfap2c (Weber et al., 2010). However,
PGC specification is also associated with reexpression or
upregulation of core pluripotency transcription factors
including Nanog, Sox2, and Klf2 (Kurimoto et al., 2008).
These factors are thought to be essential in PGCs (Cham-
bers et al., 2007; Kehler et al., 2004; Yamaguchi et al.,
2009), although their role remains unclear. Their presence
may mean that pluripotency is not extinguished in
PGCs as in other postgastrulation lineages (Osorno et al.,
2012), but could instead lie dormant. Derivation of EG
cell lines from the first specified PGCs at E7.5 is consistent
with the idea that latent pluripotency may be a necessary
feature of the germline. The efficiency of EG cell generation
does decrease during PGC development however, falling
bymore than an order ofmagnitude at E11.5. Interestingly,
this coincides temporally with widespread epigenome
modifications (Hajkova et al., 2008). Nonetheless, a
rudiment of pluripotency is retained in later germline
development as evidenced by the ability to derive a type
of pluripotent stem cell from spermatogonial stem cells
(Kanatsu-Shinohara et al., 2004; Ko et al., 2009).
In feeder-free cultures with 4Fs and GSK3 inhibition, we
observed that PGCs exhibit features of locomotor cells,
such as cell extension and lamellopodia (Movie S1). This
motile phenotype persists throughout the early pro-
liferative phase of culture for approximately 72 hr. After
this time, cell death is progressive, and only cells under-
going conversion to EG cells continue to proliferate
extensively. However, cell loss is heterogeneous and occa-
sional cells with PGC morphology survive until much
later time points. This raises the intriguing possibility
that it may be feasible to sustain PGC proliferation and
survival without EG cell formation. In this context, it
might be productive to omit LIF while employing GSK3
inhibition.
LIF does not appear important for initial PGC culture
but is specifically required to drive EG cell conversion.
Inhibition of MAPK signaling is also not required for the
initial 48 hr of PGC culture, in fact, is deleterious during
that period. Our observations suggest that EG cell forma-
tion can be divided into two discrete phases: an initial
48 hr period of PGC adaptation to culture that is pro-
moted by bFGF, RA, SCF, and GSK3 inhibition and a sub-
sequent period of fate conversion over 6 days. The secondve ES cells (Tang et al., 2010) and E8.5 PGCs (Hackett et al., 2012)
ascent EG cell colonies after 96 or 120 hr in culture. At 120 hr KLF4
g patterns. All cells in field were OCT4 positive; DAPI omitted for
ntransfected control, following transfection with two independent
rs denote SEM, ***p < 0.001, ANOVA with Newman-Keul’s post hoc,
Figure 4. STAT3 Targets Are Upregulated in Germ Cell Tumors
(A) Heatmap of STAT3 target gene expression in adult germ cell tumors. Primary data are from Korkola et al. (2006). Samples were clustered
according to the prevalent histology. Additional genes involved in pluripotency, LIF-signaling pathway, and PGC development are pro-
vided as a reference. mixed GCT, mixed germ cell tumors; S, seminoma; EC, embryonal carcinoma; YST, yolk-sac tumor; CC, choriocarcinoma;
Tera, teratoma; T, normal testis.
(B) NTk and NEk values for KEGG pathways enriched in tumor samples over normal testis. STAT3 target genes were fed into the algorithm as
a KEGG pathway (Savatier STAT3 targets, colored in red) for unbiased analysis of enrichment over other pathways. The standard JAK-STAT
KEGG pathway is shown in green. The top 20 most enriched pathways are shown below order by average rank.
(C) Model depicting PGC conversion to pluripotency in two different contexts. In vitro, the LIF/STAT3 pathway is the key requirement for
generation of EG cells. We further propose that in vivo activation of STAT3 drives the formation of the pluripotent cells that constitute
embryonal carcinoma or give rise to teratomas, the ‘‘pluripotent GCTs.’’
See also Figure S3.
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which is augmented by inhibition of GSK3. A key goal
for future studies will be to elucidate the temporal pattern
of STAT3 target gene induction and delineate the synergy
with MAPK inhibition that reconstructs the full pluri-
potency and self-renewal circuit (Nichols and Smith,
2012). The intersection between these two pathways
also appears crucial to achieve authentic induced pluripo-
tency by somatic cell reprogramming (Silva et al., 2008;
Sridharan et al., 2009; van Oosten et al., 2012; Yang
et al., 2010). Elucidating the process of EG cell formation
may therefore illuminate generally the acquisition of
pluripotency.
Given the proven ability of transcription factors to artifi-
cially induce pluripotency in somatic cells (Takahashi and
Yamanaka, 2006), the high expression of these factors in
the germline (Kurimoto et al., 2008) raises the question of
how PGCs are constrained from becoming pluripotent
and thereby tumorigenic in vivo. Our findings point
to the primacy of LIF/STAT3 signaling in driving fate
conversion. We propose that activation of the STAT3
pathway in PGCs can result in reacquisition of pluripo-
tency in two contexts—in vitro enabling the derivation
of EG cells and in vivo allowing the formation of pluripo-
tent GCTs (Figure 4C). The observation that STAT3 targets
are underrepresented in PGCs suggests that the pathway
is normally either silent or is antagonized. Indeed the LIF
receptor gp130 is not required during PGC development
(Molyneaux et al., 2003). This may be an important safe-
guard against acquisition of ectopic pluripotency.
STAT3 targets are upregulated in those GCTs that have a
pluripotent compartment, or that have transited through
a pluripotent state, suggesting that this pathway may
play a previously unappreciated role in teratocarcinogene-
sis. This may merit further investigation, notably because
inhibitors of the Jak/Stat pathway are being developed
as chemotherapeutic agents against hematological and
solid tumors (Liu et al., 2012; O’Shea et al., 2013;
Quinta´s-Cardama et al., 2011). Although, GCTs are gener-
ally responsive to cisplatin therapy, resistance does occur
particularly in teratomas (Oosterhuis and Looijenga, 2005)
and conceivably might be reduced by targeting the STAT3
pathway in combination therapy.
Finally, re-evaluation of PGCs as a robust source of
pluripotent stem cells and the pivotal role played by LIF
in the conversion process raises the possibility that the
early human germline might be a promising source of
LIF-responsive pluripotent stem cells. We speculate that
rebuilding pluripotency directly from in vivo or in vitro
derived human PGCs may allow capture of the hypotheti-
cal human naive state (De Los Angeles et al., 2012), which
has so far proved elusive starting from preimplantation
embryos.74 Stem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The AuthorsEXPERIMENTAL PROCEDURES
Animal studies were authorized by a UK Home Office Project
License and carried out in a Home Office-designated facility.EG Cell Culture
For routine culture, EG cells were maintained in 2i/LIF medium on
laminin (10 mg/ml, Sigma) or gelatin-coated plates. 2i/LIF medium
comprise the MEK inhibitor PD0325901 (PD) 1 mM, the GSK3
inhibitor CHIR99021 (CH) 3 mM, and mouse LIF 10 ng/ml
(prepared in house) in N2B27 medium (Ying et al., 2003) (Stem
Cells, SCS-SF-NB-02). Cells were expanded by dissociation with
trypsin and replating every 2–3 days.EG-Cell-Derivation Medium
Derivations were performed in N2B27 (Ying et al., 2003) with the
following additives as indicated: LIF, CH, PD (all as above), bFGF
25 nM (prepared in house), retinoic acid (RA) 2 mM (Invitrogen),
forskolin (FK) 10 mM (Sigma), stem cell factor (SCF) 100 ng/ml
(R&D), and JAK inhibitor 1 1 mM (Calbiochem). N2B27 was batch
tested for EG cell derivation. Plates were coated with human
plasma fibronectin (Millipore, 15–20 mg/ml in PBS, for 1 hr at
37C) or precoated collagen IV plates (BD, Biocoat) were used, as
indicated.EG Cell Derivation
E7.5, E8.5, and E11.5 EG cell lines were established from embryos
produced by crossing mixed background Oct4-DPE-GFP transgenic
males (Yoshimizu et al., 1999) with strain 129 female mice. EG cell
derivations from E8.5 embryos were performed essentially as
described previously (Leitch et al., 2010). In brief, the posterior
fragment of the embryo containing PGCs was dissected free of
the extraembryonic membranes and trypsinized to a single cell
suspension. Cells were collected by centrifugation. Cells were re-
suspended in derivation medium and either plated in two 2 cm2
wells per starting embryo or filtered and sorted using a MoFlo
high-speed cell sorter (Dako Cytomation). Sorted PGCs were
deposited directly into cell culture plates precoated with the indi-
cated ECM protein (as above) and containing derivation medium.
PGCs were plated at a density of approximately 12.5 cell per cm2,
or as indicated. In all experiments, sorted GFP-negative somatic
cells were cultured in parallel, and pluripotent cell colonies were
not observed. E7.5 EG cell lines were derived from the above cross,
as well as embryos produced by crossing mixed background
Blimp1-GFP (Ohinata et al., 2005) or Stella-GFP BAC (Payer et al.,
2006) transgenic males with strain 129 female mice. Embryos
were dissected at 10 a.m., and embryos more advanced than the
midallantoic bud stage (Downs and Davies, 1993) were excluded.
The posterior fragment containing PGCs was dissected and pro-
cessed as above for fluorescence activated cell sorting (FACS).
GFP-positive cells were sorted as above and plated at a density of
12.5 cells per cm2 on fibronectin-coated dishes in CH/LIF plus
bFGF, RA, SCF, and FK (4Fs). After 48 hr cultures were transitioned
to 2i/LIF medium by daily half-medium changes. E11.5 EG cell
colonies were obtained by dissecting E11.5 gonads and purifying
PGCs by FACS, as above. Sorted PGCs were plated at a density of
Stem Cell Reports
Rebuilding Pluripotency from Primordial Germ Cells1,000 cells per cm2, and EG cell derivation was performed as for
E7.5. Time-lapse imaging was performed using a Leica DMI7000.
Piggybac Transposition
E7.5 Stella-GFP EG cells (1 3 106) were transfected using Lipofect-
amine 2000 (Invitrogen) with 4 mg of the PiggyBac vector pCAG-
DsRed-IRES-Zeocin plus 2 mg of pCAGPBase (Wang et al., 2008).
The Lipofectamine/DNA complex was applied to the cells in
2i/LIF for 7 hr and then removed and replaced with freshmedium.
After 48 hr, Zeocin was added at a concentration of 100 mg/ml to
select for stable transfectants. The cells were passaged three times
over 7 days and Zeocin-resistant cells were flow-sorted. The bright-
est 20% DSRED-expressing cells were passaged as a stable pool for
morula aggregation.
RNAi Experiments
siRNAs were transfected at a final concentration of 40 nM using
Lipofectamine RNAiMAX (Invitrogen). For a 24-well plate
(2 cm2), we used 1 ml of transfection reagent, 1 ml of 20 mM siRNA
solution, and 400 ml of N2B27 medium. PGCs were sorted and
plated on fibronectin-coated plates 30 hr before transfection.
The medium was changed after 10 hr incubation. STAT3 siRNAs
were purchased from QIAGEN (catalog numbers are indicated in
parentheses): siSTAT3_1 (SI01435287), siSTAT3_2 (SI01435294),
siSTAT3_3 (SI01435301), and siSTAT3_4 (SI01435308). GFP
siRNAs were custom made (target sequence: GCAAGCTGACCTG
AAGTTCA).
Chimera Production
Midgestation chimeras were generated by morula aggregation of
fluorescent E7.5 EG cells with E2.5 embryos (Nagy et al., 2003).
Term chimeras were produced by microinjection of E7.5 or E8.5
EG cells (agouti) into C57Bl/6 blastocysts (Nagy et al., 2003).
Immunostaining
Immunostaining was performed using standard protocols. Briefly,
cells were fixed in 4% paraformaldehyde for 10 min, blocked, and
permeabilized in PBS, 0.1% Triton X-100, and 1% BSA. Primary
antibodies were incubated in the same buffer overnight at 4C.
Secondary antibodies were incubated for 1 hr at room temperature.
Plates were washed 33 15min in PBS after primary and secondary
antibody incubations. Nuclei were stained with DAPI. Primary
antibodies were: OCT4 (BD, 1:200) and KLF4 (R&D Systems,
3:500). Nuclei were stained with DAPI. Alexa Fluor secondary
antibodies (Invitrogen) were used at 1:500 dilution.
Reanalysis of Published RNA-seq and Microarray Data
STAT3 targets (Bourillot et al., 2009) were compared between
RNA-seq data sets for Oct4-positive ES cells (Tang et al., 2010)
and E8.5 PGCs (Hackett et al., 2012) and mean reads per million
(RPM) depicted as a scatterplot. Previously published microarray
data of adult germ cell tumors (Korkola et al., 2006) were obtained
from GEO (accession number GSE3218). Raw data files were
analyzed in R/Bioconductor with the affy package and RMA
normalized. To construct the heatmap, the normalized values of
STAT3 target gene expression were log2 transformed and centeredaround the median. Pathway analysis was performed using the
sigPathway package (http://bioconductor.org/packages/release/
bioc/html/sigPathway.html). To create a customized gene set ob-
ject, the G file specific for the humanmicroarray used in this study,
hgu133a (Tian et al., 2005), was modified to include a Savatier
STAT3 targets category, containing the probes for the reported
STAT3 target genes. The NTk and NEk enrichment values obtained
for KEGG pathways were plotted against each other, and the path-
ways were ordered by average rank.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, and
one movie and can be found with this article online at http://dx.
doi.org/10.1016/j.stemcr.2013.03.004.LICENSING INFORMATION
This is an open-access article distributed under the terms of the
Creative Commons Attribution-NonCommercial-No Derivative
Works License, which permits non-commercial use, distribution,
and reproduction in any medium, provided the original author
and source are credited.ACKNOWLEDGMENTS
We thank Sam Jameson, Keith Savill, and staff for excellent animal
husbandry; Nigel Miller (Department of Pathology, University of
Cambridge) for flow cytometry support; and Bill Mansfield and
Charles-E´tienne Dumeau for chimera generation. We thank Petra
Hajkova, Kirsten McEwen, and Ian Adams for helpful discussions.
We thankMarkoHyvonen for production of recombinant LIF. This
study was funded by the Biotechnology and Biological Sciences
Research Council and the Medical Research Council of the United
Kingdom and by the Swiss National Science Foundation Sinergia
program. A.S. is a Medical Research Council Professor.
Received: January 31, 2013
Revised: March 22, 2013
Accepted: March 23, 2013
Published: June 4, 2013REFERENCES
Bao, S., Tang, F., Li, X., Hayashi, K., Gillich, A., Lao, K., and Surani,
M.A. (2009). Epigenetic reversion of post-implantation epiblast to
pluripotent embryonic stem cells. Nature 461, 1292–1295.
Blair, K., Leitch, H.G., Mansfield, W., Dumeau, C.-E´., Humphreys,
P., and Smith, A.G. (2012). Culture parameters for stable expan-
sion, genetic modification and germline transmission of rat
pluripotent stem cells. Biology Open 1, 58–65.
Bourillot, P.-Y., Aksoy, I., Schreiber, V., Wianny, F., Schulz, H.,
Hummel, O., Hubner, N., and Savatier, P. (2009). Novel STAT3
target genes exert distinct roles in the inhibition of mesoderm
and endoderm differentiation in cooperation with Nanog. Stem
Cells 27, 1760–1771.Stem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The Authors 75
Stem Cell Reports
Rebuilding Pluripotency from Primordial Germ CellsBrook, F.A., and Gardner, R.L. (1997). The origin and efficient
derivation of embryonic stem cells in the mouse. Proc. Natl.
Acad. Sci. USA 94, 5709–5712.
Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B., Robert-
son, M., Vrana, J., Jones, K., Grotewold, L., and Smith, A. (2007).
Nanog safeguards pluripotency and mediates germline develop-
ment. Nature 450, 1230–1234.
De Felici, M., Pesce, M., Giustiniani, Q., and Di Carlo, A. (1998).
In vitro adhesiveness of mouse primordial germ cells to cellular
and extracellular matrix component substrata. Microsc. Res.
Tech. 43, 258–264.
De Los Angeles, A., Loh, Y.-H., Tesar, P.J., and Daley, G.Q. (2012).
Accessing naı¨ve human pluripotency. Curr. Opin. Genet. Dev.
22, 272–282.
De Miguel, M.P., Cheng, L., Holland, E.C., Federspiel, M.J., and
Donovan, P.J. (2002). Dissection of the c-Kit signaling pathway
in mouse primordial germ cells by retroviral-mediated gene trans-
fer. Proc. Natl. Acad. Sci. USA 99, 10458–10463.
Dolci, S., Williams, D.E., Ernst, M.K., Resnick, J.L., Brannan, C.I.,
Lock, L.F., Lyman, S.D., Boswell, H.S., and Donovan, P.J. (1991).
Requirement for mast cell growth factor for primordial germ cell
survival in culture. Nature 352, 809–811.
Downs, K.M., and Davies, T. (1993). Staging of gastrulating mouse
embryos by morphological landmarks in the dissecting micro-
scope. Development 118, 1255–1266.
Durcova-Hills, G., and Capel, B. (2008). Development of germ cells
in the mouse. Curr. Top. Dev. Biol. 83, 185–212.
Durcova-Hills, G., Adams, I.R., Barton, S.C., Surani, M.A., and
McLaren, A. (2006). The role of exogenous fibroblast growth
factor-2 on the reprogramming of primordial germ cells into
pluripotent stem cells. Stem Cells 24, 1441–1449.
Durcova-Hills, G., Tang, F., Doody, G., Tooze, R., and Surani, M.A.
(2008). Reprogramming primordial germ cells into pluripotent
stem cells. PLoS ONE 3, e3531.
Godin, I., Deed, R., Cooke, J., Zsebo, K., Dexter,M., andWylie, C.C.
(1991). Effects of the steel gene product onmouse primordial germ
cells in culture. Nature 352, 807–809.
Guo, G., Yang, J., Nichols, J., Hall, J.S., Eyres, I., Mansfield, W., and
Smith, A. (2009). Klf4 reverts developmentally programmed
restriction of ground state pluripotency. Development 136,
1063–1069.
Hackett, J.A., Sengupta, R., Zylicz, J.J., Murakami, K., Lee, C.,
Down, T.A., and Surani, M.A. (2012). Germline DNA demethyla-
tion dynamics and imprint erasure through 5-hydroxymethylcy-
tosine. Science 339, 448–452.
Hajkova, P., Ancelin, K., Waldmann, T., Lacoste, N., Lange, U.C.,
Cesari, F., Lee, C., Almouzni, G., Schneider, R., and Surani, M.A.
(2008). Chromatin dynamics during epigenetic reprogramming
in the mouse germ line. Nature 452, 877–881.
Hall, J., Guo, G., Wray, J., Eyres, I., Nichols, J., Grotewold, L.,
Morfopoulou, S., Humphreys, P., Mansfield, W., Walker, R., et al.
(2009). Oct4 and LIF/Stat3 additively induce Kru¨ppel factors
to sustain embryonic stem cell self-renewal. Cell Stem Cell 5,
597–609.76 Stem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The AuthorsKanatsu-Shinohara,M., Inoue, K., Lee, J., Yoshimoto,M., Ogonuki,
N., Miki, H., Baba, S., Kato, T., Kazuki, Y., Toyokuni, S., et al. (2004).
Generation of pluripotent stem cells from neonatal mouse testis.
Cell 119, 1001–1012.
Kehler, J., Tolkunova, E., Koschorz, B., Pesce, M., Gentile, L.,
Boiani, M., Lomelı´, H., Nagy, A., McLaughlin, K.J., Scho¨ler, H.R.,
and Tomilin, A. (2004). Oct4 is required for primordial germ cell
survival. EMBO Rep. 5, 1078–1083.
Kimura, T., Suzuki, A., Fujita, Y., Yomogida, K., Lomelı´, H., Asada,
N., Ikeuchi, M., Nagy, A., Mak, T.W., and Nakano, T. (2003). Con-
ditional loss of PTEN leads to testicular teratoma and enhances em-
bryonic germ cell production. Development 130, 1691–1700.
Kimura, T., Tomooka, M., Yamano, N., Murayama, K., Matoba, S.,
Umehara, H., Kanai, Y., and Nakano, T. (2008). AKT signaling pro-
motes derivation of embryonic germ cells from primordial germ
cells. Development 135, 869–879.
Ko, K., Tapia, N., Wu, G., Kim, J.B., Bravo, M.J.A., Sasse, P., Glaser,
T., Ruau, D., Han, D.W., Greber, B., et al. (2009). Induction of plu-
ripotency in adult unipotent germline stem cells. Cell Stem Cell 5,
87–96.
Korkola, J.E., Houldsworth, J., Chadalavada, R.S., Olshen, A.B.,
Dobrzynski, D., Reuter, V.E., Bosl, G.J., and Chaganti, R.S. (2006).
Down-regulation of stem cell genes, including those in a 200-kb
gene cluster at 12p13.31, is associated with in vivo differentiation
of human male germ cell tumors. Cancer Res. 66, 820–827.
Koshimizu, U., Taga, T., Watanabe, M., Saito, M., Shirayoshi, Y.,
Kishimoto, T., and Nakatsuji, N. (1996). Functional requirement
of gp130-mediated signaling for growth and survival of mouse pri-
mordial germ cells in vitro and derivation of embryonic germ (EG)
cells. Development 122, 1235–1242.
Kurimoto, K., Yabuta, Y., Ohinata, Y., Shigeta, M., Yamanaka, K.,
and Saitou, M. (2008). Complex genome-wide transcription dy-
namics orchestrated by Blimp1 for the specification of the germ
cell lineage in mice. Genes Dev. 22, 1617–1635.
Labosky, P.A., Barlow, D.P., and Hogan, B.L. (1994). Mouse embry-
onic germ (EG) cell lines: transmission through the germline and
differences in the methylation imprint of insulin-like growth fac-
tor 2 receptor (Igf2r) gene compared with embryonic stem (ES)
cell lines. Development 120, 3197–3204.
Leitch, H.G., Blair, K., Mansfield, W., Ayetey, H., Humphreys, P.,
Nichols, J., Surani, M.A., and Smith, A. (2010). Embryonic germ
cells from mice and rats exhibit properties consistent with a
generic pluripotent ground state. Development 137, 2279–2287.
Li, Y., McClintick, J., Zhong, L., Edenberg, H.J., Yoder, M.C., and
Chan, R.J. (2005). Murine embryonic stem cell differentiation is
promoted by SOCS-3 and inhibited by the zinc finger transcription
factor Klf4. Blood 105, 635–637.
Liu, X., Guo, W., Wu, S., Wang, L., Wang, J., Dai, B., Kim, E.S.,
Heymach, J.V., Wang, M., Girard, L., et al. (2012). Antitumor activ-
ity of a novel STAT3 inhibitor and redox modulator in non-small
cell lung cancer cells. Biochem. Pharmacol. 83, 1456–1464.
Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofe-
meister, H., Nichols, J., Kranz, A., Stewart, A.F., Smith, A., and
Stunnenberg, H.G. (2012). The transcriptional and epigenomic
foundations of ground state pluripotency. Cell 149, 590–604.
Stem Cell Reports
Rebuilding Pluripotency from Primordial Germ CellsMatsuda, T., Nakamura, T., Nakao, K., Arai, T., Katsuki, M., Heike,
T., and Yokota, T. (1999). STAT3 activation is sufficient tomaintain
an undifferentiated state of mouse embryonic stem cells. EMBO J.
18, 4261–4269.
Matsui, Y., Toksoz, D., Nishikawa, S., Nishikawa, S., Williams, D.,
Zsebo, K., and Hogan, B.L. (1991). Effect of Steel factor and
leukaemia inhibitory factor on murine primordial germ cells in
culture. Nature 353, 750–752.
Matsui, Y., Zsebo, K., and Hogan, B.L. (1992). Derivation of pluri-
potential embryonic stem cells frommurine primordial germ cells
in culture. Cell 70, 841–847.
McLaren, A., and Lawson, K.A. (2005). How is themouse germ-cell
lineage established? Differentiation 73, 435–437.
Molyneaux, K.A., Schaible, K., and Wylie, C. (2003). GP130, the
shared receptor for the LIF/IL6 cytokine family in the mouse, is
not required for early germ cell differentiation, but is required
cell-autonomously in oocytes for ovulation. Development 130,
4287–4294.
Nagamatsu, G., Kosaka, T., Saito, S., Takubo, K., Akiyama, H., Sudo,
T., Horimoto, K., Oya, M., and Suda, T. (2012). Tracing the conver-
sion process from primordial germ cells to pluripotent stem cells
in mice. Biol. Reprod. 86, 182.
Nagy, A., Gertsenstein,M., Vintersten, K., and Behringer, R. (2003).
Manipulating the Mouse Embryo (New York: Cold Spring Harbor
Laboratory Press).
Nichols, J., and Smith, A. (2012). Pluripotency in the embryo and
in culture. Cold Spring Harb. Perspect. Biol. 4, a008128.
Niwa, H., Burdon, T., Chambers, I., and Smith, A. (1998). Self-
renewal of pluripotent embryonic stem cells is mediated via acti-
vation of STAT3. Genes Dev. 12, 2048–2060.
Niwa, H., Ogawa, K., Shimosato, D., and Adachi, K. (2009).
A parallel circuit of LIF signalling pathways maintains pluripo-
tency of mouse ES cells. Nature 460, 118–122.
O’Shea, J.J., Holland, S.M., and Staudt, L.M. (2013). JAKs and STATs
in immunity, immunodeficiency, and cancer. N. Engl. J. Med. 368,
161–170.
Ohinata, Y., Payer, B., O’Carroll, D., Ancelin, K., Ono, Y., Sano, M.,
Barton, S.C., Obukhanych, T., Nussenzweig, M., Tarakhovsky, A.,
et al. (2005). Blimp1 is a critical determinant of the germ cell
lineage in mice. Nature 436, 207–213.
Oosterhuis, J.W., and Looijenga, L.H.J. (2005). Testicular germ-cell
tumours in a broader perspective. Nat. Rev. Cancer 5, 210–222.
Osorno, R., Tsakiridis, A., Wong, F., Cambray, N., Economou, C.,
Wilkie, R., Blin, G., Scotting, P.J., Chambers, I., and Wilson, V.
(2012). The developmental dismantling of pluripotency is reversed
by ectopic Oct4 expression. Development 139, 2288–2298.
Payer, B., Chuva de Sousa Lopes, S.M., Barton, S.C., Lee, C., Saitou,
M., and Surani, M.A. (2006). Generation of stella-GFP transgenic
mice: a novel tool to study germ cell development. Genesis 44,
75–83.
Quinta´s-Cardama, A., Kantarjian, H., Cortes, J., and Verstovsek, S.
(2011). Janus kinase inhibitors for the treatment of myeloprolifer-
ative neoplasias and beyond. Nat. Rev. Drug Discov. 10, 127–140.Resnick, J.L., Bixler, L.S., Cheng, L., and Donovan, P.J. (1992).
Long-term proliferation of mouse primordial germ cells in culture.
Nature 359, 550–551.
Rugg-Gunn, P.J., Cox, B.J., Lanner, F., Sharma, P., Ignatchenko, V.,
McDonald, A.C.H., Garner, J., Gramolini, A.O., Rossant, J., and
Kislinger, T. (2012). Cell-surface proteomics identifies lineage-
specific markers of embryo-derived stem cells. Dev. Cell 22,
887–901.
Saitou, M., Barton, S.C., and Surani, M.A. (2002). A molecular pro-
gramme for the specification of germ cell fate in mice. Nature 418,
293–300.
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen,
T.W., and Smith, A. (2008). Promotion of reprogramming to
ground state pluripotency by signal inhibition. PLoS Biol. 6, e253.
Sperger, J.M., Chen, X., Draper, J.S., Antosiewicz, J.E., Chon, C.H.,
Jones, S.B., Brooks, J.D., Andrews, P.W., Brown, P.O., and Thomson,
J.A. (2003). Gene expression patterns in human embryonic stem
cells and human pluripotent germ cell tumors. Proc. Natl. Acad.
Sci. USA 100, 13350–13355.
Sridharan, R., Tchieu, J., Mason, M.J., Yachechko, R., Kuoy, E.,
Horvath, S., Zhou, Q., and Plath, K. (2009). Role of the murine
reprogramming factors in the induction of pluripotency. Cell
136, 364–377.
Stevens, L.C. (1967). Origin of testicular teratomas fromprimordial
germ cells in mice. J. Natl. Cancer Inst. 38, 549–552.
Stewart, C.L., Gadi, I., and Bhatt, H. (1994). Stem cells fromprimor-
dial germ cells can reenter the germ line. Dev. Biol. 161, 626–628.
Surani, M.A. (2007). Germ cells: the eternal link between genera-
tions. C. R. Biol. 330, 474–478.
Surani, M.A., Hayashi, K., and Hajkova, P. (2007). Genetic and
epigenetic regulators of pluripotency. Cell 128, 747–762.
Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent
stem cells from mouse embryonic and adult fibroblast cultures
by defined factors. Cell 126, 663–676.
Tang, F., Barbacioru, C., Bao, S., Lee, C., Nordman, E., Wang, X.,
Lao, K., and Surani, M.A. (2010). Tracing the derivation of embry-
onic stem cells from the inner cell mass by single-cell RNA-Seq
analysis. Cell Stem Cell 6, 468–478.
Tian, L., Greenberg, S.A., Kong, S.W., Altschuler, J., Kohane, I.S.,
and Park, P.J. (2005). Discovering statistically significant pathways
in expression profiling studies. Proc. Natl. Acad. Sci. USA 102,
13544–13549.
van Oosten, A.L., Costa, Y., Smith, A., and Silva, J.C. (2012). JAK/
STAT3 signalling is sufficient and dominant over antagonistic cues
for the establishment of naive pluripotency. Nat. Commun. 3, 817.
Wang, W., Lin, C., Lu, D., Ning, Z., Cox, T., Melvin, D., Wang, X.,
Bradley, A., and Liu, P. (2008). Chromosomal transposition of
PiggyBac in mouse embryonic stem cells. Proc. Natl. Acad. Sci.
USA 105, 9290–9295.
Weber, S., Eckert, D., Nettersheim, D., Gillis, A.J.M., Scha¨fer, S.,
Kuckenberg, P., Ehlermann, J., Werling, U., Biermann, K.,
Looijenga, L.H.J., and Schorle, H. (2010). Critical function of
AP-2 gamma/TCFAP2C in mouse embryonic germ cell main-
tenance. Biol. Reprod. 82, 214–223.Stem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The Authors 77
Stem Cell Reports
Rebuilding Pluripotency from Primordial Germ CellsWest, J.A., Viswanathan, S.R., Yabuuchi, A., Cunniff, K., Takeuchi,
A., Park, I.-H., Sero, J.E., Zhu, H., Perez-Atayde, A., Frazier, A.L.,
et al. (2009). A role for Lin28 in primordial germ-cell development
and germ-cell malignancy. Nature 460, 909–913.
Yamaguchi, S., Kurimoto, K., Yabuta, Y., Sasaki, H., Nakatsuji, N.,
Saitou, M., and Tada, T. (2009). Conditional knockdown of Nanog
induces apoptotic cell death in mouse migrating primordial germ
cells. Development 136, 4011–4020.
Yamaji, M., Seki, Y., Kurimoto, K., Yabuta, Y., Yuasa, M., Shigeta,
M., Yamanaka, K., Ohinata, Y., and Saitou, M. (2008). Critical
function of Prdm14 for the establishment of the germ cell
lineage in mice. Nat. Genet. 40, 1016–1022.
Yang, J., van Oosten, A.L., Theunissen, T.W., Guo, G., Silva,
J.C.R., and Smith, A. (2010). Stat3 activation is limiting for78 Stem Cell Reports j Vol. 1 j 66–78 j June 4, 2013 j ª2013 The Authorsreprogramming to ground state pluripotency. Cell Stem Cell 7,
319–328.
Ying, Q.-L., Stavridis, M., Griffiths, D., Li, M., and Smith, A.
(2003). Conversion of embryonic stem cells into neuroectoder-
mal precursors in adherent monoculture. Nat. Biotechnol. 21,
183–186.
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B.,
Woodgett, J., Cohen, P., and Smith, A. (2008). The ground state
of embryonic stem cell self-renewal. Nature 453, 519–523.
Yoshimizu, T., Sugiyama, N., De Felice, M., Yeom, Y.I., Ohbo, K.,
Masuko, K., Obinata, M., Abe, K., Scho¨ler, H.R., and Matsui, Y.
(1999). Germline-specific expression of the Oct-4/green fluores-
cent protein (GFP) transgene in mice. Dev. Growth Differ. 41,
675–684.
